BioSpace News Archive

Business

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies.

January 28, 2022
·
18 min read
Business

NovaBay Pharmaceuticals Announces Changes to Its Board of Directors

NovaBay ® Pharmaceuticals, Inc . announces the appointments of Audrey Kunin, M.D. and Julie Garlikov to the NovaBay Board of Directors.

January 28, 2022
·
6 min read
Business

Monrol Signing Agreement to License its GMP Grade Lu-177 n.c.a Production Technology to Curium

Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177 Lu (n.c.a. 177 Lu) cutting-edge production technology LuMagic®.

January 28, 2022
·
4 min read
Biotech Beach

FDA Accepts Label Update for Plasma IQ™, the First FDA-Cleared Handheld Plasma Energy Device

Suneva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted updates to the Plasma IQ ™ label, including the removal of the product’s eye contraindication.

January 28, 2022
·
10 min read
Business

Updates on OLUMIANT® (baricitinib) Phase 3 lupus program and FDA review for atopic dermatitis

Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) today announced updates on the Phase 3 development program for OLUMIANT ® (baricitinib) in adults with active systemic lupus erythematosus (also referred to as SLE and lupus) and the status of the U.S. atopic dermatitis supplemental new drug application (sNDA).

January 28, 2022
·
21 min read
Business

Legendary Designer and Fashion Icon, Iris Apfel, Joins the Bone Health and Osteoporosis Foundation’s Ambassadors Leadership Council

The Bone Health and Osteoporosis Foundation (BHOF) today welcomed Iris Apfel to its Ambassadors Leadership Council.

January 28, 2022
·
2 min read
Genetown

Blueprint Medicines’ AYVAKYT® (avapritinib) Receives Positive CHMP Opinion for the Treatment of Adults with Advanced Systemic Mastocytosis

Positive opinion based on results from two clinical trials that comprise the largest clinical trial dataset in advanced systemic mastocytosis.

January 28, 2022
·
10 min read
Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that has listed a component of its ART and ECLS systems on the U.S. Food and Drug Administration Class I 510(k) exempt list.

January 28, 2022
·
2 min read
Genetown

ENVI Announces Quorum to Pass Business Combination With GreenLight Biosciences and Achievement of All Transaction Requirements Following the Redemption Deadline

Environmental Impact Acquisition Corporation (“ENVI” or the “Company”) (Nasdaq: ENVI) today announced that it had achieved a quorum for the special meeting of its shareholders to be held on February 1, 2022 (the “Special Meeting”), in connection with its business combination with GreenLight Biosciences Inc. (“GreenLight”), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture

January 28, 2022
·
8 min read
Business

CARRA Appoints Larry Hausner as Interim CEO

Childhood Arthritis and Rheumatology Research Alliance (CARRA) announced its appointment of Larry Hausner as interim chief executive officer, effective today.

January 28, 2022
·
2 min read